Medicare Part D coverage · 3 · RxCUI 2380256

3 ML insulin lispro-aabc 200 UNT/ML Pen Injector [Lyumjev]

Per the CMS 2026 Part D formulary file, 3 ML insulin lispro-aabc 200 UNT/ML Pen Injector [Lyumjev] is covered by 1,584 Medicare Part D plans (31.4% of enrollable products), averaging Tier 2.7, with prior authorization required on 0.8% of covering formularies.

31.4%
Plan coverage
1,584
Plans covering
T2.7
Avg tier
0.8%
Prior auth required

Verify with CMS →

Important: Drug coverage and costs vary by plan and location. Verify coverage directly with your Medicare plan before filling a prescription. This is informational data only and should not replace advice from your healthcare provider or pharmacist.

What the CMS Formulary Data Shows for 3 ML insulin lispro-aabc 200 UNT/ML Pen Injector [Lyumjev]

Per the CMS 2026 Part D formulary file, 3 ML insulin lispro-aabc 200 UNT/ML Pen Injector [Lyumjev] (RxNorm concept RXCUI 2380256, generic name 3) appears on 124 distinct formulary files spanning 1,584 Medicare Part D plan offerings - 31.4% of enrollable Part D products, selective placement; verify formulary inclusion before enrolling. Tier placement ranges from Tier 1 to Tier 6, with a cross-plan average of Tier 2.7.

Real-world access to 3 ML insulin lispro-aabc 200 UNT/ML Pen Injector [Lyumjev] depends on utilization management as much as tier placement: 0.8% of covering formularies require prior authorization. 0% require step therapy. 34.7% apply quantity limits.

Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 3,723 Part D beneficiaries filled 3 ML insulin lispro-aabc 200 UNT/ML Pen Injector [Lyumjev] in 2023, with total plan-and-beneficiary spending of $14,719,969 and an average per-beneficiary annual cost of $3,953.79. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry 3 ML insulin lispro-aabc 200 UNT/ML Pen Injector [Lyumjev] today.

Coverage Details

Formularies covering
124
Plans covering
1,584
Coverage rate
31.4%
Tier range
Tier 1 – Tier 6
Average tier
Tier 3, Preferred Brand

Restrictions

Prior authorization required
0.8% of formularies
Step therapy required
0% of formularies
Quantity limits
34.7% of formularies

2023 Medicare Spending

Beneficiaries
3,723
Total spending
$14,719,969
Avg per beneficiary
$3,953.79

Tier Distribution Across Plans

81 plans
Tier 1, Preferred Generic
19 plans
Tier 3, Preferred Brand

Standalone Drug Plans (PDP) Covering 3 ML insulin lispro-aabc 200 UNT/ML Pen Injector [Lyumjev]

2 standalone prescription drug plans include this drug.

Plan Insurer Tier PA ST Premium States
AARP Medicare Rx Preferred from UHC (PDP) Unitedhealthcare INS. Co. & UHC INS. Co. OF NY T3 No No $0 -
AARP Medicare Rx Preferred from UHC (PDP) Unitedhealthcare INS. Co. & UHC INS. Co. OF NY T3 No No $0 -

Medicare Advantage Plans (MA-PD) Covering 3 ML insulin lispro-aabc 200 UNT/ML Pen Injector [Lyumjev]

98 Medicare Advantage plans with Part D drug coverage include this drug.

Plan Insurer Tier PA Premium States
ElderServe MAP (HMO D-SNP) Elderserve Health, Inc. T1 No $0 NY
Cooperative Advantage (HMO D-SNP) Group Health Cooperative OF EAU Claire T1 No $0 WI
Longevity Health Plan (PPO I-SNP) Longevity Health Plan OF NEW Jersey Insurance Comp T1 No $0 NJ
Upper Peninsula Health Plan MI Coordinated Health (HMO D-SNP) Upper Peninsula Health Plan, LLC T1 No $0 MI
CareSource Dual Advantage (HMO D-SNP) Caresource Georgia Co. T1 No $0 GA
HAP CareSource MI Coordinated Health (HMO D-SNP) HAP Caresource T1 No $0 MI
PruittHealth Premier D-SNP (HMO D-SNP) Pruitthealth Premier, Inc. T1 No $0 GA
Simpra Advantage Dual Care (PPO D-SNP) Simpra Advantage, Inc. T1 No $0 AL
Gold Coast Health Plan Total Care Advantage (HMO D-SNP) Ventura County Medi-Cal Managed Care Commission T1 No $0 CA
Blue Cross Medicare Advantage Dual Care Plus (HMO D-SNP) Health Care Service Corporation T1 No $0 NM
Blue Cross MA Dual Care Plus Preferred (PPO D-SNP) Health Care Service Corporation T1 No $0 NM
Horizon NJ TotalCare (HMO D-SNP) Horizon Healthcare OF NEW Jersey, Inc. T1 No $0 NJ
SecureBlue (HMO D-SNP) HMO Minnesota T1 No $0 MN
Hamaspik Medicare Choice (HMO D-SNP) Hamaspik, Inc. T1 No $0 NY
CCA One Care (HMO D-SNP) Commonwealth Care Alliance, Inc. T1 No $0 MA
CCA Senior Care Options (HMO D-SNP) Commonwealth Care Alliance, Inc. T1 No $0 MA
Provider Partners Pennsylvania Community Plan (HMO I-SNP) Provider Partners Health Plan OF Pennsylvania, Inc T1 No $0 PA
Provider Partners North Carolina Community Plan (HMO I-SNP) Provider Partners Health Plan OF North Carolina T1 No $0 NC
Provider Partners Indiana Community Plan (HMO I-SNP) Provider Partners Health Plan OF Indiana T1 No $0 IN
Provider Partners Missouri Community Plan (HMO I-SNP) Provider Partners Health Plan OF Missouri, Inc. T1 No $0 MO
Show the next 30 plans
Longevity Health Plan (HMO I-SNP) Longevity Health Plan OF Florida, Inc. T1 No $4.80 FL
Senior Care (HMO I-SNP) Align Senior Care Florida, Inc. T1 No $4.80 FL
ProCare Advantage (HMO-POS I-SNP) Procare Advantage, LLC T1 No $4.80 TX
ProCare Advantage - Kidney Care (HMO-POS C-SNP) Procare Advantage, LLC T1 No $4.80 TX
American Health Advantage of Florida (HMO I-SNP) American Health Plan OF FL, Inc. T1 No $4.80 FL
SECUR Advantage (HMO I-SNP) Secur Inc T1 No $4.80 FL
SECUR Enhanced (HMO I-SNP) Secur Inc T1 No $4.80 FL
Blue Cross Medicare Advantage Dual Care Plus (HMO D-SNP) Hcsc Insurance Services Company T1 No $4.80 TX
Provider Partners Texas Advantage Plan (HMO I-SNP) Provider Partners Health Plan OF Texas, Inc. T1 No $4.80 TX
Blue Cross Medicare Advantage Dual Care Plus (HMO D-SNP) GHS Insurance Company T1 No $5.00 OK
Longevity Health Plan (HMO I-SNP) Longevity Health Plan OF Michigan, Inc. T1 No $8.80 MI
Senior Care (HMO I-SNP) Align Senior Care MI, LLC T1 No $8.80 MI
AgeRight Advantage Health Plan (HMO I-SNP) Marquis Advantage, Inc. T1 No $10.50 OR, WA
Senior Care (HMO I-SNP) Align Senior Care California Inc. T1 No $12.00 CA
Liberty Medicare Dual Plan (HMO D-SNP) Liberty Advantage, LLC T1 No $14.70 NC
Longevity Health Plan (HMO I-SNP) Longevity Health Plan OF Illinois, Inc. T1 No $15.20 IL
Provider Partners Illinois Advantage Plan (HMO I-SNP) Provider Partners Health Plan OF Illinois T1 No $15.20 IL
WellSense Added Value (HMO) Boston Medical Center Health Plan, Inc. T1 No $21.70 NH
KeyCare Advantage (HMO I-SNP) Isnp Ventures, LLC T1 No $23.20 MD
American Health Advantage of Mississippi (HMO I-SNP) American Health Plan OF MS, Inc. T1 No $23.80 MS
Senior Care (HMO I-SNP) Lifeworks Advantage, LLC T1 No $24.60 VA
PruittHealth Premier (HMO I-SNP) Pruitthealth Premier, Inc. T1 No $25.40 GA
Georgia Health Advantage (HMO I-SNP) Georgia Assurance, Inc. T1 No $25.40 GA
Georgia Health Advantage Choice (HMO I-SNP) Georgia Assurance, Inc. T1 No $25.40 GA
American Health Advantage of Tennessee (HMO I-SNP) American Health Plan, Inc. T1 No $27.70 TN
Simpra Advantage Nursing Home Plan (PPO I-SNP) Simpra Advantage, Inc. T1 No $27.70 AL
American Health Advantage of Oklahoma (HMO I-SNP) Oklahoma Superior Select, Inc. T1 No $28.20 OK
NHC Advantage (HMO I-SNP) NHC Advantage, LLC T1 No $31.00 MO, NC, SC, TN
Perennial Advantage Strive (HMO I-SNP) Perennial Advantage OF Ohio, Inc. T1 No $31.40 OH
Perennial Advantage Strive (HMO I-SNP) Perennial Advantage OF Colorado, Inc. T1 No $32.70 PA

Showing top 50 of 98 plans.

Frequently Asked Questions

Is 3 ML insulin lispro-aabc 200 UNT/ML Pen Injector [Lyumjev] covered by Medicare Part D?

Yes, 3 ML insulin lispro-aabc 200 UNT/ML Pen Injector [Lyumjev] is covered by 1,584 Medicare Part D plans (31.4% of all Part D formularies).

What tier is 3 ML insulin lispro-aabc 200 UNT/ML Pen Injector [Lyumjev] on Medicare Part D plans?

3 ML insulin lispro-aabc 200 UNT/ML Pen Injector [Lyumjev] averages Tier 2.7 across Part D plans, ranging from Tier 1 to Tier 6.

Does 3 ML insulin lispro-aabc 200 UNT/ML Pen Injector [Lyumjev] require prior authorization?

0.8% of Part D formularies require prior authorization for 3 ML insulin lispro-aabc 200 UNT/ML Pen Injector [Lyumjev]. Step therapy: 0%. Quantity limits: 34.7%.

How much does Medicare spend on 3 ML insulin lispro-aabc 200 UNT/ML Pen Injector [Lyumjev]?

In 2023, total Medicare Part D spending on 3 ML insulin lispro-aabc 200 UNT/ML Pen Injector [Lyumjev] was $14,719,969, covering 3,723 beneficiaries. The average spend per beneficiary was $3,953.79.

Nationwide similar Part D drugs

Data-derived peers across the CMS Part D formulary extract: nearest average tier placement and nearest prior-authorization rate. Not therapeutic alternatives or same-generic strengths.

Data sourced from the Centers for Medicare & Medicaid Services (CMS). See our methodology for details. Retrieved and formatted by PlainMedicare